Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ursodeoxycholic acid and primary biliary cirrhosis.

Literature DB >> 8086896

Ursodeoxycholic acid and primary biliary cirrhosis.

A G Lim, T C Northfield.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Ursodeoxycholic Acid

Year: 1994 PMID： 8086896 PMCID： PMC2542706 DOI： 10.1136/bmj.309.6953.491

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

13 in total

1. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.

Authors: Y Calmus; P Gane; P Rouger; R Poupon
Journal: Hepatology Date: 1990-01 Impact factor: 17.425

2. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis.

Authors: S Krähenbühl; J Stucki; J Reichen
Journal: Hepatology Date: 1992-06 Impact factor: 17.425

3. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

Authors: R E Poupon; B Balkau; E Eschwège; R Poupon
Journal: N Engl J Med Date: 1991-05-30 Impact factor: 91.245

4. Hepatoprotective properties of ursodeoxycholic acid.

Authors: D M Heuman
Journal: Gastroenterology Date: 1993-06 Impact factor: 22.682

5. Immunomodulatory effects of ursodeoxycholic acid on immune responses.

Authors: M Yoshikawa; T Tsujii; K Matsumura; J Yamao; Y Matsumura; R Kubo; H Fukui; S Ishizaka
Journal: Hepatology Date: 1992-08 Impact factor: 17.425

6. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

Authors: R P Jazrawi; J S de Caestecker; P M Goggin; A J Britten; A E Joseph; J D Maxwell; T C Northfield
Journal: Gastroenterology Date: 1994-01 Impact factor: 22.682

7. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.

Authors: U Leuschner; M Leuschner; J Sieratzki; W Kurtz; K Hübner
Journal: Dig Dis Sci Date: 1985-07 Impact factor: 3.199

Ursodeoxycholic acid and primary biliary cirrhosis.

1. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.

2. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis.

3. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

4. Hepatoprotective properties of ursodeoxycholic acid.

5. Immunomodulatory effects of ursodeoxycholic acid on immune responses.

6. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

7. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.

8. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.

9. Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].

10. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.

1. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.